Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 5;44(1):121-128.
doi: 10.1093/jbcr/irac099.

Experience with Implementing a Beta-lactam Therapeutic Drug Monitoring Service in a Burn Intensive Care Unit: A Retrospective Chart Review

Affiliations

Experience with Implementing a Beta-lactam Therapeutic Drug Monitoring Service in a Burn Intensive Care Unit: A Retrospective Chart Review

Mohammad Alshaer et al. J Burn Care Res. .

Abstract

Thermal injuries alter pharmacokinetics, complicating the prediction of standard antibiotic dose effectiveness. Therapeutic drug monitoring (TDM) has been proposed to prevent subtherapeutic dosing of antibiotic therapy, but remains scarcely studied in the burn patient population. A retrospective chart review of burn patients receiving beta-lactam TDM from 2016 to 2019 was conducted. Adult patients with thermal injury receiving cefepime, piperacillin/tazobactam, or meropenem for ≥48 hours were included. Between February 2016 and July 2017, we utilized selective TDM based on clinical judgement to guide treatment. From October 2018 until July 2019, TDM was expanded to all burn patients on beta-lactams. The primary endpoint was achievement of therapeutic concentration, and the secondary endpoints were clinical cure, culture clearance, new resistance, length of stay, and mortality. The selective (control) group included 19 patients and the universal (study) group reviewed 23 patients. In both groups, skin and lungs were the most common primary infection sources, with Pseudomonas aeruginosa as the most common species. In the universal cohort, patients were older with higher risk factors, but more frequently achieved the target drug concentration, required less days to start TDM (p < .0001), and had more frequent measurements and beta-lactam dose adjustments. Positive clinical outcome was reported in 77%, and microbial eradication in 82% of all patients. All clinical outcomes were similar between the groups. The implementation of beta-lactam TDM protocol shortened the time, increased the probability of appropriate target attainment, and individualized beta-lactam therapy in burn patients.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Beta-lactams dose adjustment based on the TDM protocol.
Figure 2.
Figure 2.
Variability in beta-lactams Cmin/MIC ratios with the first episode of TDM for each patient. White line represents the median, IQR is the gray shaded area dn the range is displayed as a gray line.

References

    1. Lachiewicz AM, Hauck CG, Weber DJ, Cairns BA, van Duin D. Bacterial infections after burn injuries: impact of multidrug resistance. Clin Infect Dis 2017;65:2130–6. - PMC - PubMed
    1. Sharma BR, Harish D, Singh VP, Bangar S. Septicemia as a cause of death in burns: an autopsy study. Burns 2006;32:545–9. - PubMed
    1. Dvorak JE, Ladhani HA, Claridge JA. Review of sepsis in burn patients in 2020. Surg Infect 2021;22:37–43. Erratum in: Surg Infect (Larchmt). 2021 Nov;22:989. - PubMed
    1. Miller SF, Bessey PQ, Schurr MJ, et al. . National Burn Repository 2005: a ten-year review. J Burn Care Res 2006;27:411–36. - PubMed
    1. Williams FN, Herndon DN, Hawkins HK, et al. . The leading causes of death after burn injury in a single pediatric burn center. Crit Care 2009;13:R183. - PMC - PubMed

Publication types